Table 3.

HR-HPV viral load at enrollment and association with persistent infection over two years stratified by trial arm.

	Intervention		Control		Overall
	High Viral Load^	Low Viral Load^	High Viral Load^	Low Viral Load^	High Viral Load^	Low Viral Load^
	Persistent HR-HPV / N* (%)	Persistent HR-HPV / N* (%)	Persistent HR-HPV / N* (%)	Persistent HR-HPV / N* (%)	Persistent HR-HPV / N* (%)	Persistent HR-HPV / N* (%)
Year One	89/207 (43.0%)	35/145 (24.1%)	83/210 (39.5%)	36/128 (28.1%)	172/417 (41.2%)	71/273 (26.0%)
Year Two	27/89 (30.3%)	16/35 (45.7%)	48/83 (57.8%)	17/36 (47.2%)	75/172 (43.6%)	33/71 (46.5%)
Hazard Ratio	1.07 (0.92 - 1.24)		1.24 (1.06 - 1.46)		1.15 (1.03 - 1.28)
adjHR#	1.24 (0.99 - 1.55)		1.25 (0.98 - 1.60)		1.27 (1.07 - 1.50)

^{^}High HR-HPV viral load includes a linear array band signal strength of 3 or 4 which represents >200 copies/5μl. Low HR-HPV viral load comprises a linear array band signal strength of 1 or 2.

^*N is the number of total genotypes detected at enrollment classified as either high VL or low VL.

^#adjHR is an adjusted Hazard Ratio. The Hazard multivariate analysis adjusted for age in all models and circumcision status of male partner for the overall model.